OpenAI on Thursday unveiled GPT-Rosalind, an AI model with advanced biology and research capabilities. Named after the 20th-century British scientist Rosalind Franklin, it is aimed at supporting work across biochemistry, drug discovery and translational medicine. The model can help researchers query databases, read scientific papers, use tools and propose new experiments.